And the clinical plan is in Stage III development.

AbbVie receives HUMIRA orphan drug designation from FDA for treatment of non-infectious uveitis AbbVie announced today that the U.S . AbbVie is certainly investigating the security and efficacy of HUMIRA for the treatment of non-infectious uveitis, and the clinical plan is in Stage III development. HUMIRA isn’t currently approved to take care of any type of uveitis. Related StoriesCurrent and brand-new remedies for AMD: an interview with Dr Alan Cruess, AMD Alliance InternationalCurrent problems in tackling macular degeneration: an interview with Tag Ackermann, AMD Alliance InternationalUveitis is usually an over-all term that encompasses many inflammatory eye diseases. The associated swelling causes damage of eye tissue leading to reduced eyesight and/or vision loss.

To learn more about The Scientist, go to About Abbott Abbott is usually a global, broad-based health care company devoted to the discovery, development, marketing and manufacture of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The ongoing company employs a lot more than 72, 000 markets and folks its products in more than 130 countries. Abbott’s news releases and other information can be found on the company’s Web site at.. Abbott Named One of the Top 10 Companies for Scientists Abbott was recently named one of the Top 10 10 businesses on The Scientist magazine’s ‘Best Places to Work in Sector’ list. Abbott was rated No. 6 one of many Large Companies .